Cours Amarillo Biosciences, Inc. Other OTC
Actions
AMAR
US02301P2056
Recherche biotechnologique et médicale
CA 2022 | 3,52 M 3,19 M | CA 2023 | 122 k 111 k | Capitalisation | 8,32 M 7,54 M |
---|---|---|---|---|---|
Résultat net 2022 | -14 M -12,7 M | Résultat net 2023 | -13 M -11,79 M | VE / CA 2022 | 3,36 x |
Trésorerie nette 2022 | 585 k 530 k | Dette nette 2023 | 3,81 M 3,45 M | VE / CA 2023 | 99,3 x |
PER 2022 |
-0,6
x | PER 2023 |
-0,61
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 45,29% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 15/04/21 |
Lawrence Lin
COO | Chief Operating Officer | 55 | 01/08/21 |
Shu Ying Pan
SAM | Sales & Marketing | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Yao Chung Chiang
BRD | Director/Board Member | 70 | 15/04/21 |
Pao Sheng Wei
BRD | Director/Board Member | 66 | 15/06/22 |
Chung Yi Tsai
BRD | Director/Board Member | 47 | 15/04/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
-1,65% | 103 Md | |
+6,75% | 101 Md | |
+6,72% | 23,07 Md | |
-12,60% | 22,23 Md | |
-5,34% | 18,05 Md | |
-39,98% | 17,18 Md | |
-10,17% | 16,94 Md | |
+6,12% | 14,07 Md | |
+35,47% | 12,35 Md |